Join our community of smart investors

Smith & Nephew resurrection

The medical devices maker is set to haul itself higher again before long
July 1, 2013

Having upped its dividend and announced a share buyback, Smith & Nephew is set to reap the rewards on its share price chart, says Thomas Light at www.galvan.co.uk

The price began its current up-move back in October and has stayed above its 200-day moving average line since November. There is plenty of support above this widely watched line, too, and the target for the ongoing rally is around 800p.